The company located in San Mateo de Gállego will soon be presenting its solutions for the diagnosis of infectious diseases in Japan and Germany, while also consolidating its international growth.
CerTest is unstoppable. Activity in the first half of 2019 was intense, with exhibitions in Dubai, Nanchang (China), Amsterdam, Barcelona and Anaheim (USA), which have served to demonstrate the good times currently enjoyed by the company, who, in recent years, has seen how its turnover has increased by more than 300%, with a staff of more than 140, four business units operating in more than 130 countries and a clear customer-directed service and orientation.
CerTest conducts research into, develops and distributes diagnosis techniques for infectious diseases. With more than 7000 square metres of facilities, the company looks to the future with optimism. It is already preparing its next events abroad, with exhibitions at the most relevant and influential events in the sector on a global level, events which bring together the best international profiles in the clinical diagnosis sector.
After exhibiting in the United States of America, CerTest’s next appointments in its agenda take it to Japan (JACLaS, Yokohama) in October and Germany (MEDICA, Düsseldorf) in November; this last one is the most important annual event in the sector, with more than 6000 exhibiting firms from all over the world. This is where CerTest will launch a renewed and improved space, from where they will attend to all the visitors and demonstrate the new features of the product and services for the diagnosis of infectious diseases.
Further information about the company, its products, services and forthcoming events can be found at www.certest.es